BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 38847244)

  • 1. Low Expression of GRIM-19 Correlates with Poor Prognosis in Patients with Upper Urinary Tract Urothelial Carcinoma.
    Tian F; Lv L; Liu Z; Guan S; Jiang F; Wang Q; Kalvakolanu DV; Jiang S; Sun W
    Curr Cancer Drug Targets; 2024 Jun; ():. PubMed ID: 38847244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GATA3 immunohistochemistry in urothelial carcinoma of the upper urinary tract as a urothelial marker and a prognosticator.
    Inoue S; Mizushima T; Fujita K; Meliti A; Ide H; Yamaguchi S; Fushimi H; Netto GJ; Nonomura N; Miyamoto H
    Hum Pathol; 2017 Jun; 64():83-90. PubMed ID: 28428106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of steroid hormone receptors and its prognostic significance in urothelial carcinoma of the upper urinary tract.
    Kashiwagi E; Fujita K; Yamaguchi S; Fushimi H; Ide H; Inoue S; Mizushima T; Reis LO; Sharma R; Netto GJ; Nonomura N; Miyamoto H
    Cancer Biol Ther; 2016 Nov; 17(11):1188-1196. PubMed ID: 27635763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Significance of Preoperative Serum Lactate Dehydrogenase in Upper Urinary Tract Urothelial Carcinoma.
    Zhang XK; Zhang ZL; Lu X; Yang P; Cai MY; Hu WM; Yun JP; Zhou FJ; Qian CN; Cao Y
    Clin Genitourin Cancer; 2016 Aug; 14(4):341-345.e3. PubMed ID: 26868330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant chemotherapy after radical nephroureterectomy improves the survival outcome of high-risk upper tract urothelial carcinoma patients with cardiovascular comorbidity.
    Luo Y; Feng B; Wei D; Han Y; Li M; Zhao J; Lin Y; Hou Z; Jiang Y
    Sci Rep; 2020 Oct; 10(1):17674. PubMed ID: 33077839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NFATc1 Expression as a Prognosticator in Urothelial Carcinoma of the Upper Urinary Tract.
    Kawahara T; Inoue S; Fujita K; Mizushima T; Ide H; Yamaguchi S; Fushimi H; Nonomura N; Miyamoto H
    Transl Oncol; 2017 Jun; 10(3):318-323. PubMed ID: 28327458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HER2 protein overexpression and gene amplification in upper urinary tract urothelial carcinoma-an analysis of 171 patients.
    Sasaki Y; Sasaki T; Kawai T; Morikawa T; Matsusaka K; Kunita A; Kume H; Aoki I; Homma Y; Fukayama M
    Int J Clin Exp Pathol; 2014; 7(2):699-708. PubMed ID: 24551292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GRIM-19 expression is a potent prognostic marker in colorectal cancer.
    Hao M; Shu Z; Sun H; Sun R; Wang Y; Liu T; Ji D; Cong X
    Hum Pathol; 2015 Dec; 46(12):1815-20. PubMed ID: 26363526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative C-reactive protein to albumin ratio as a novel prognostic biomarker for the oncological outcomes of radical nephroureterectomy.
    Gwak CH; Suh J; Lim B; Song C; You D; Jeong IG; Hong JH; Hong B; Ahn H
    Urol Oncol; 2024 Feb; 42(2):30.e17-30.e23. PubMed ID: 38072737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uridine 5'diphospho-glucuronosyltransferase 1A expression as an independent prognosticator in urothelial carcinoma of the upper urinary tract.
    Izumi K; Inoue S; Ide H; Fujita K; Mizushima T; Jiang G; Yamaguchi S; Fushimi H; Nonomura N; Miyamoto H
    Int J Urol; 2018 May; 25(5):429-435. PubMed ID: 29444544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective analysis of Ki-67 as an independent predictor of oncologic outcomes in patients with high grade upper tract urothelial carcinoma.
    Krabbe LM; Bagrodia A; Lotan Y; Gayed BA; Darwish OM; Youssef RF; John G; Harrow B; Jacobs C; Gaitonde M; Sagalowsky AI; Shariat SF; Kapur P; Margulis V
    J Urol; 2014 Jan; 191(1):28-34. PubMed ID: 23871758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor budding in upper urinary tract urothelial carcinoma: a putative prognostic factor for extraurothelial recurrence and overall survival.
    Kawamura K; Miyai K; Asakuma J; Sato K; Matsukuma S; Tsuda H; Ito K
    Virchows Arch; 2021 Jul; 479(1):45-55. PubMed ID: 33404852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear, but not cytoplasmic, localization of survivin as a negative prognostic factor for survival in upper urinary tract urothelial carcinoma.
    Kitamura H; Torigoe T; Hirohashi Y; Asanuma H; Inoue R; Nishida S; Tanaka T; Masumori N; Sato N; Tsukamoto T
    Virchows Arch; 2013 Jan; 462(1):101-7. PubMed ID: 23179762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemistry of cytokeratin (CK) 5/6, CD44 and CK20 as prognostic biomarkers of non-muscle-invasive papillary upper tract urothelial carcinoma.
    Jung M; Kim B; Moon KC
    Histopathology; 2019 Feb; 74(3):483-493. PubMed ID: 30286252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of double J stenting or nephrostomy placement during transurethral resection of bladder tumour on the incidence of metachronous upper urinary tract urothelial cancer.
    Hupe MC; Dormayer L; Ozimek T; Struck JP; Hennig MJP; Klee M; von Klot CAJ; Kuczyk MA; Merseburger AS; Kramer MW
    BMC Cancer; 2020 Feb; 20(1):140. PubMed ID: 32085750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression and clinical significance of GRIM-19 in epithelial ovarian carcinoma].
    Shao YP; Cheng XD; Wan XY
    Zhonghua Fu Chan Ke Za Zhi; 2012 Oct; 47(10):751-5. PubMed ID: 23302733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Female Gender Is an Age-dependent Negative Prognostic Factor for Patients with Upper Tract Urothelial Carcinoma.
    Sikic D; Wach S; Taubert H; Richterstetter M; Kunath F; Goebell PJ; Schick S; Olbert P; Huber J; Wullich B; Keck B
    Anticancer Res; 2015 Jul; 35(7):4277-81. PubMed ID: 26124390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bimodal pattern of the impact of body mass index on cancer-specific survival of upper urinary tract urothelial carcinoma patients.
    Ishioka J; Masuda H; Kijima T; Tatokoro M; Yoshida S; Yokoyama M; Matsuoka Y; Numao N; Koga F; Saito K; Fujii Y; Sakai Y; Arisawa C; Okuno T; Nagahama K; Kamata S; Yonese J; Kageyama Y; Noro A; Morimoto S; Tsujii T; Kitahara S; Gotoh S; Kihara K
    Anticancer Res; 2014 Oct; 34(10):5683-8. PubMed ID: 25275074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Forkhead box O1 as an indicator of prognosis is inactivated in urothelial carcinoma of the upper urinary tract.
    Ide H; Jiang G; Mizushima T; Fujita K; Inoue S; Yamaguchi S; Fushimi H; Nonomura N; Miyamoto H
    Oncol Lett; 2019 Jan; 17(1):482-487. PubMed ID: 30655790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of preoperative neutrophil-lymphocyte, lymphocyte-monocyte, and platelet-lymphocyte ratios in patients with upper urinary tract urothelial carcinoma undergoing radical nephroureterectomy.
    Song X; Zhang GM; Ma XC; Luo L; Li B; Chai DY; Sun LJ
    Onco Targets Ther; 2016; 9():1399-407. PubMed ID: 27042108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.